This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Chemical Industry Looking Up: 5 Top Growth Stocks to Scoop Up
by Anindya Barman
A strong rebound in China's economy and recovering manufacturing activities around the world augur well for the chemical industry.
5 Materials Stocks to Make the Most of Economic Recovery
by Zacks Equity Research
U.S. economy is poised for a rebound on positive COVID-19 vaccine developments and hopes of a fiscal stimulus, making it prudent to invest in stocks like Bunge (BG) and Cabot (CBT) from the materials sector.
Markets Hit Record Highs, Promise Further Growth: 5 Top Picks
by Zacks Equity Research
Promising vaccine news and hopes of further fiscal stimulus helped benchmark indexes to close at record highs, making this a prudent time to invest in names like Cabot (CBT) and Forestar (FOR)
Global Chemical Output Leaps as Recovery Continues to Take Hold
by Anindya Barman
A rebound in demand across major end markets has put the wind back in the sails of the chemical industry.
What Makes Cabot (CBT) a Solid Investment Option Right Now
by Zacks Equity Research
Cabot (CBT) benefits from a recovery in demand in automotive and tire markets and the Shenzhen Sanshun Nano acquisition.
New Strong Buy Stocks for November 30th
by Zacks Equity Research
Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List today.
Top Ranked Value Stocks to Buy for November 30th
by Zacks Equity Research
Here are three stocks with buy rank and strong value characteristics for investors to consider today, November 30th.
Cabot (CBT) Surpasses Earnings and Sales Estimates in Q4
by Zacks Equity Research
Cabot (CBT) saw a rebound in volumes in its Reinforcement Materials segment on a sequential comparison basis in Q4.
Is Cabot (CBT) a Solid Growth Stock? 3 Reasons to Think " Yes "
by Zacks Equity Research
Cabot (CBT) possesses solid growth attributes, which could help it handily outperform the market.
What Makes Cabot (CBT) a New Buy Stock
by Zacks Equity Research
Cabot (CBT) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Is Cabot (CBT) Stock Undervalued Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Will Cost Control Aid Helmerich & Payne's (HP) Q4 Earnings?
by Zacks Equity Research
Helmerich & Payne's (HP) cost-reduction efforts are likely to have boosted its fourth-quarter fiscal 2020 earnings and cash flows.
Cabot (CBT) Introduces New Black Masterbatch Formulation
by Zacks Equity Research
Per Cabot (CBT), the Plasblak XP6801D black masterbatch will assist customers to innovate and provide formulation flexibility.
Cabot (CBT) Expands E2C Line With First Product in New Series
by Zacks Equity Research
The latest addition to E2C family of solutions highlights Cabot's (CBT) commitment to assist tire producers reach performance goals.
Cabot (CBT) Issues an Update on Business Results for Q4
by Zacks Equity Research
Cabot's (CBT) margins in the Performance Chemicals unit are expected to be driven by higher volumes in Performance Additives.
Air Products (APD) to Post Q4 Earnings: What's in the Offing?
by Zacks Equity Research
Air Products' (APD) Q4 results are likely to reflect the unfavorable impacts from the coronavirus pandemic and volumes pressure.
Should You Buy Cabot (CBT) Ahead of Earnings?
by Zacks Equity Research
Cabot (CBT) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
Daqo New Energy (DQ) to Post Q3 Earnings: What's in Store?
by Zacks Equity Research
Daqo New Energy's (DQ) third-quarter results are expected to reflect the benefits of higher production volumes.
What's in the Cards for Lithium Americas (LAC) Q3 Earnings?
by Zacks Equity Research
Exploration costs related to the Thacker Pass project are likely to have affected Lithium Americas' (LAC) bottom line in the third quarter.
Albemarle (ALB) to Report Q3 Earnings: What's in the Cards?
by Zacks Equity Research
Benefits of cost-saving initiatives are expected to get reflected on Albemarle's (ALB) Q3 results.
L.B. Foster (FSTR) to Post Q3 earnings: What's in Store?
by Zacks Equity Research
L.B. Foster (FSTR) is likely to have gained from improved order activities across its Rail and Construction segments in Q3.
FMC Corp (FMC) to Report Q3 Earnings: What's in the Offing?
by Zacks Equity Research
Strong demand for FMC Corp's (FMC) products and benefits of new product launches are likely to get reflected on its Q3 results.
Vale (VALE) Gears Up to Report Q3 Earnings: What's in Store?
by Zacks Equity Research
Vale's (VALE) third-quarter results are likely to reflect higher iron ore production and rising iron ore prices.
Coeur Mining (CDE) to Report Q3 Earnings: What's in Store?
by Zacks Equity Research
Coeur Mining's (CDE) third-quarter results are likely to reflect resumption of operations at Palmarejo, strong results from its three U.S. operations, and higher gold and silver prices.
3 Reasons Why Cabot (CBT) Is a Great Growth Stock
by Zacks Equity Research
Cabot (CBT) possesses solid growth attributes, which could help it handily outperform the market.